Picumast

CAS No. 39577-19-0

Picumast( —— )

Catalog No. M36215 CAS No. 39577-19-0

Picumast shows antiallergic activity and can be utilized in the treatment of asthma. Picumast may be used in the treatment of therapeutic allergic airway diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 409 Get Quote
10MG 604 Get Quote
25MG 908 Get Quote
50MG 1251 Get Quote
100MG 1647 Get Quote
500MG 3312 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Picumast
  • Note
    Research use only, not for human use.
  • Brief Description
    Picumast shows antiallergic activity and can be utilized in the treatment of asthma. Picumast may be used in the treatment of therapeutic allergic airway diseases.
  • Description
    Picumast shows antiallergic activity and can be utilized in the treatment of asthma. Picumast may be used in the treatment of therapeutic allergic airway diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    39577-19-0
  • Formula Weight
    440.96
  • Molecular Formula
    C25H29ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C=2C(=CC(OCCCN3CCN(CC4=CC=C(Cl)C=C4)CC3)=CC2)OC(=O)C1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Mulberrofuran Q

    Mulberrofuran Q is an active compound that inhibits the formation of 12-hydroxy-5,8,10-heptadecatrienoic acid (HHT) and thromboxane B2 (cyclooxygenase product) , which protects neuronal cells from hypoxia-glycorrhoea-deficiency (OGD)-induced oxidative stress.

  • Panaxadiol

    Panaxadiol is a novel antitumor agent extracted from the Chinese medical herb Panax ginseng.

  • Obtustatin

    Highly potent integrin α1β1 inhibitor (IC50 = 0.8 nM for α1β1 binding to type IV collagen). Selective for α1β1 over α2β1, αIIbβ3, αvβ3, α4β1, α5β6, α9β1 and α4β7. Inhibits FGF2-stimulated angiogenesis in the chicken chorioallantoic model. Displays antitumor efficacy in a synergistic mouse model of Lewis lung carcinoma; blocks human melanoma growth in nude mice.